Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1614 1618
This examiner grants 40% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19344192 | ULTRASOUND MEDIATED DELIVERY OF DRUGS | Non-Final OA | EXACT Therapeutics AS |
| 17433298 | METABOLIC ANALYSIS METHOD | Final Rejection | BASF SE |
| 19175507 | POLYOLS AND POLYOL-BASED HYDROGELS WITH ANTI-CANCER ACTIVITY | Non-Final OA | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES |
| 19299911 | PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA | Non-Final OA | CONTERA PHARMA A/S |
| 19063950 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | Non-Final OA | Generation Bio Co. |
| 18248191 | METHODS AND COMPOSITIONS FOR IMAGING AND TREATING CANCER | Non-Final OA | WASHINGTON UNIVERSITY |
| 18042779 | OPHTHALMIC DYE | Non-Final OA | Vitreq B.V. |
| 18263826 | PHEROMONE DIFFUSING GEL | Non-Final OA | VIRBAC |
| 18189658 | Competitive Self-Blocking with Unlabeled Manocept Imaging Agents | Non-Final OA | Cardinal Health 414, LLC |
| 18219656 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | Non-Final OA | MICROVASCULAR THERAPEUTICS, LLC |
| 17616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | Final Rejection | MICROVASCULAR THERAPEUTICS, LLC |
| 17612968 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | Final Rejection | NIRvana Sciences Inc. |
| 17439282 | Ophthalmic Compositions, and Ocular Uses Thereof, of Indigo Carmine | Final Rejection | ZEBRA BIOTECH PTY LTD |
| 17424166 | RADIOACTIVE ISOTOPE-LABELED, PHOTO-CROSSLINKABLE HYDROGEL, AND PREPARATION METHOD THEREFOR | Non-Final OA | SNVIA CO., LTD. |
| 16864136 | LIPID ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODS | Non-Final OA | Lantheus Medical Imaging, Inc. |
| 18009290 | ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS SYSTEM | Non-Final OA | Vesigen, Inc. |
| 17594243 | IMPLANTABLE DEPOTS FOR THE LOCALIZED, SUSTAINED, CONTROLLED RELEASE OF THERAPEUTIC AGENTS TO TREAT CANCER AND RELATED SYMPTOMS AND CONDITIONS | Non-Final OA | Foundry Therapeutics, Inc. |
| 17433736 | DYNAMIC COVALENTLY LINKED HYDROGELS AS STABILIZATION NETWORK PLATFORMS | Non-Final OA | NANOLY BIOSCIENCE, INC. |
| 17255424 | Theranostic Radiophotodynamic Therapy Nanoparticles | Non-Final OA | The Governers of the University of Alberta |
| 17209921 | ANTIBIOTIC ELUTING POLY(ESTER UREA) FILMS, MESHES AND POUCHES FOR INFECTION CONTROL OF IMPLANTABLE MEDICAL DEVICES | Final Rejection | 21st Century Medical Technologies, LLC |
| 17277803 | METHODS OF TREATING CANCER | Final Rejection | Mike SATHEKGE |
| 17149547 | METHODS TO INCREASE MILK YIELD AND YIELD OF MILK CONSTITUENTS IN LACTATING RUMINANTS | Non-Final OA | Nutreco IP Assets B.V. |
| 16644142 | SONO-RESPONSIVE EMBOLIC AGENTS | Final Rejection | IMBIOTECHNOLOGIES LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy